246
Participants
Start Date
April 30, 2010
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
Fosaprepitant dimeglumine
Addition of fosaprepitant dimeglumine 150 mg IV single dose weekly (before chemotherapy) to dexamethasone and palonosetron.
Placebo
Saline water
Rigshospitalet, Finsen Centret, Copenhagen
Herlev Hospital, Herlev
RAH Cancer Centre, Royal Adelaide Hospital, Adelaide SA
Department of Oncology, Odense University Hospital, Odense
Department of Oncology, Aarhus
Universitatsklinikum Schleswig Holstein, Kiel
Vivantes Klinikum Neukolln, Berlin
The Norwegian Radium Hospital, Oslo
Collaborators (1)
Helsinn Healthcare SA
INDUSTRY
Odense University Hospital
OTHER